Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00899951 · ClinicalTrials.gov registry record
Studying Fentanyl in Patients With Cancer
A clinical trial, sponsored by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins.
- Terminated
- Registry status
- 2
- Enrollment target
NCT00899951: Clinical Trial study, sponsored by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins.
NCT00899951 is a clinical trial that was terminated before completion, run by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins. The registered enrollment target is 2 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00899951 was terminated before completion, sponsored by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins.
- TERMINATED
- Registry status
- 2 participants
- Enrollment target
Study Summary
RATIONALE: Studying blood samples from cancer patients undergoing pain treatment in the laboratory may help doctors learn more about how pain drugs work in the body. It may also help doctors predict how patients will respond to treatment. PURPOSE: This research study is looking at fentanyl in patients with cancer.
Interventions
- OTHER pharmacological study
- DRUG fentanyl citrate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2007-10 |
| Est. Completion | 2009-07 |
Why NCT00899951 stopped before completion
NCT00899951 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 2 participants, a relatively small participant target.
The record links to 0 conditions, and to 2 interventions - of which pharmacological study is the first listed.
NCT00899951 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00899951 about?
NCT00899951 is a clinical study titled "Studying Fentanyl in Patients With Cancer". RATIONALE: Studying blood samples from cancer patients undergoing pain treatment in the laboratory may help doctors learn more about how pain drugs work in the body. It may also help doctors predict how patients will respond to treatment. PURPOSE: This research study is looking at fentanyl in patie...
What is the current status of trial NCT00899951?
This trial is currently terminated. The enrollment target is 2 participants. The study started on 2007-10. Estimated completion is 2009-07.
What interventions are being tested in trial NCT00899951?
The interventions under investigation include: pharmacological study (OTHER), fentanyl citrate (DRUG).
Who is sponsoring clinical trial NCT00899951?
This trial is sponsored by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, which has 523 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia